Compare LYFT Inc (LYFT) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Nuwellis Inc — how do they compare? LYFT Inc trades at $16.21 (market cap $6.11B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: LYFT Inc is far larger — about 2777.3× Nuwellis Inc's market cap, and LYFT Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LYFT Inc for 47 Days and Nuwellis Inc for 26 Days on average.
| LYFT | NUWE | |
|---|---|---|
Market Cap | $6.11B | $2.20M |
Volume | 13,504,560 | 121,544 |
Sector | Technology | Health |
52-Week High | $24.57 | $146.65 |
52-Week Low | $12.65 | $0.68 |
Typical Hold Time | 47 Days | 26 Days |
Enterprise Value | $5.57B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft (LYFT) trades at $16.27, up 4.29% with bullish technical signals from moving averages and ADX indicators. The company shows remarkable financial improvement with 2025 revenue of $6.32B and net income of $2.84B, achieving a 45.02% profit margin. Recent developments include European expansion and a $272.5M legal settlement. Valuation metrics appear attractive with P/E of 2.35 and P/S of 0.96, though EV/EBITDA remains elevated at 34.55.
Lyft presents a mixed investment case with strong profitability growth offset by competitive pressures and regulatory risks. The stock trades below analyst consensus target of $18.07, offering potential upside, but faces challenges from driver classification lawsuits and market saturation concerns. Recent earnings misses and high RSI levels suggest near-term volatility despite positive cash flow trends and institutional support.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
